FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Volume 341:1-7 July 1, 1999 Number 1 Next

	Full Text PDF Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Mitral-valve prolapse has been described as a common disease with frequent complications. To determine the prevalence of mitral-valve prolapse in the general population, as diagnosed with the use of current two-dimensional echocardiographic criteria, we examined the echocardiograms of 1845 women and 1646 men (mean [±SD] age, 54.7±10.0 years) who participated in the fifth examination of the offspring cohort of the Framingham Heart Study.

Methods Classic mitral-valve prolapse was defined as superior displacement of the mitral leaflets of more than 2 mm during systole and as a maximal leaflet thickness of at least 5 mm during diastasis, and nonclassic prolapse was defined as displacement of more than 2 mm, with a maximal thickness of less than 5 mm.

Results A total of 84 subjects (2.4 percent) had mitral-valve prolapse: 47 (1.3 percent) had classic prolapse, and 37 (1.1 percent) had nonclassic prolapse. Their age and sex distributions were similar to those of the subjects without prolapse. None of the subjects with prolapse had a history of heart failure, one (1.2 percent) had atrial fibrillation, one (1.2 percent) had cerebrovascular disease, and three (3.6 percent) had syncope, as compared with unadjusted prevalences of these findings in the subjects without prolapse of 0.7, 1.7, 1.5, and 3.0 percent, respectively. The frequencies of chest pain, dyspnea, and electrocardiographic abnormalities were similar among subjects with prolapse and those without prolapse. The subjects with prolapse were leaner (P<0.001) and had a greater degree of mitral regurgitation than those without prolapse, but on average the regurgitation was classified as trace or mild.

Conclusions In a community-based sample of the population, the prevalence of mitral-valve prolapse was lower than previously reported. The prevalence of adverse sequelae commonly associated with mitral-valve prolapse in studies of patients referred for that diagnosis was also low.

Source Information

From the National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, Mass. (L.A.F., D.L., M.G.L., J.C.E., D.L.F., B.L., E.J.B.); the Cardiology Division, Department of Medicine, Massachusetts General Hospital, Boston (L.A.F., R.A.L.); Harvard Medical School, Boston (L.A.F., D.L., R.A.L.); the National Heart, Lung, and Blood Institute, Bethesda, Md. (D.L.); the Divisions of Cardiology and Clinical Epidemiology, Beth Israel Deaconess Medical Center, Boston (D.L.); and the Divisions of Cardiology (D.L., E.J.B.) and Epidemiology and Preventive Medicine (D.L., M.G.L., J.C.E., E.J.B.), Boston University School of Medicine, Boston.

Address reprint requests to Dr. Benjamin at the Framingham Heart Study, Boston University School of Medicine, 5 Thurber St., Framingham, MA 01702-6334, or at emelia{at}fram.nhlbi. nih.gov.

Full Text of this Article

Related Letters:

Mitral-Valve Prolapse
Jeresaty R. M., Cheng T. O., Freed L. A., Levy D., Levine R. A., Evans J. C., Benjamin E. J.
Extract | Full Text  
N Engl J Med 1999; 341:1471-1472, Nov 4, 1999. Correspondence

This article has been cited by other articles:

• Evangelopoulos, M., Toumanidis, S, Sotou, D, Evangelopoulos, C, Mavrikakis, M, Alevizaki, M, Dimopoulos, M. (2009). Mitral valve prolapse in young healthy individuals. An early index of autoimmunity?. Lupus 18: 436-440 [Abstract]  
• WRITING GROUP MEMBERS, , Lloyd-Jones, D., Adams, R., Carnethon, M., De Simone, G., Ferguson, T. B., Flegal, K., Ford, E., Furie, K., Go, A., Greenlund, K., Haase, N., Hailpern, S., Ho, M., Howard, V., Kissela, B., Kittner, S., Lackland, D., Lisabeth, L., Marelli, A., McDermott, M., Meigs, J., Mozaffarian, D., Nichol, G., O'Donnell, C., Roger, V., Rosamond, W., Sacco, R., Sorlie, P., Stafford, R., Steinberger, J., Thom, T., Wasserthiel-Smoller, S., Wong, N., Wylie-Rosett, J., Hong, Y., for the American Heart Association Statistics Comm, (2009). Heart Disease and Stroke Statistics--2009 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119: e21-e181 [Full Text]  
• Bajona, P., Katz, W. E., Daly, R. C., Zehr, K. J., Speziali, G. (2009). Beating-heart, off-pump mitral valve repair by implantation of artificial chordae tendineae: an acute in vivo animal study.. J. Thorac. Cardiovasc. Surg. 137: 188-193 [Abstract] [Full Text]  
• Thomas, M. P., Wang, A. (2008). Taken Out of Context. NEJM 359: 2478-2482 [Full Text]  
• Avierinos, J.-F., Inamo, J., Grigioni, F., Gersh, B., Shub, C., Enriquez-Sarano, M. (2008). Sex Differences in Morphology and Outcomes of Mitral Valve Prolapse. ANN INTERN MED 149: 787-794 [Abstract] [Full Text]  
• Kim, R. D., Greenberg, D. E., Ehrmantraut, M. E., Guide, S. V., Ding, L., Shea, Y., Brown, M. R., Chernick, M., Steagall, W. K., Glasgow, C. G., Lin, J., Jolley, C., Sorbara, L., Raffeld, M., Hill, S., Avila, N., Sachdev, V., Barnhart, L. A., Anderson, V. L., Claypool, R., Hilligoss, D. M., Garofalo, M., Fitzgerald, A., Anaya-O'Brien, S., Darnell, D., DeCastro, R., Menning, H. M., Ricklefs, S. M., Porcella, S. F., Olivier, K. N., Moss, J., Holland, S. M. (2008). Pulmonary Nontuberculous Mycobacterial Disease: Prospective Study of a Distinct Preexisting Syndrome. Am. J. Respir. Crit. Care Med. 178: 1066-1074 [Abstract] [Full Text]  
• 2006 WRITING COMMITTEE MEMBERS, , Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C. Jr, Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O'Gara, P. T., O'Rourke, R. A., Otto, C. M., Shah, P. M., Shanewise, J. S. (2008). 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 118: e523-e661 [Full Text]  
• Jelinek, M. (2008). Spectrum bias: why generalists and specialists do not connect. Evid. Based Med. 13: 132-133 [Full Text]  
• Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C. Jr, Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O'Gara, P. T., O'Rourke, R. A., Otto, C. M., Shah, P. M., Shanewise, J. S., Nishimura, R. A., Carabello, B. A., Faxon, D. P., Freed, M. D., Lytle, B. W., O'Gara, P. T., O'Rourke, R. A., Shah, P. M. (2008). 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 52: e1-e142 [Full Text]  
• Gillinov, A. M., Blackstone, E. H., Alaulaqi, A., Sabik, J. F. III, Mihaljevic, T., Svensson, L. G., Houghtaling, P. L., Salemi, A., Johnston, D. R., Lytle, B. W. (2008). Outcomes After Repair of the Anterior Mitral Leaflet for Degenerative Disease. Ann. Thorac. Surg. 86: 708-717 [Abstract] [Full Text]  
• Salem, D. N., O'Gara, P. T., Madias, C., Pauker, S. G. (2008). Valvular and Structural Heart Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133: 593S-629S [Abstract] [Full Text]  
• Albers, G. W., Amarenco, P., Easton, J. D., Sacco, R. L., Teal, P. (2008). Antithrombotic and Thrombolytic Therapy for Ischemic Stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133: 630S-669S [Abstract] [Full Text]  
• Rice, S. G., and the Council on Sports Medicine and Fitness, (2008). Medical Conditions Affecting Sports Participation. Pediatrics 121: 841-848 [Abstract] [Full Text]  
• Mittnacht, A. J., Fanshawe, M., Konstadt, S. (2008). Anesthetic Considerations in the Patient With Valvular Heart Disease Undergoing Noncardiac Surgery. SEMIN CARDIOTHORAC VASC ANESTH 12: 33-59 [Abstract]  
• Donnelly, K. B. (2008). Cardiac Valvular Pathology: Comparative Pathology and Animal Models of Acquired Cardiac Valvular Diseases. Toxicol Pathol 36: 204-217 [Abstract] [Full Text]  
• Writing Group Members, , Rosamond, W., Flegal, K., Furie, K., Go, A., Greenlund, K., Haase, N., Hailpern, S. M., Ho, M., Howard, V., Kissela, B., Kittner, S., Lloyd-Jones, D., McDermott, M., Meigs, J., Moy, C., Nichol, G., O'Donnell, C., Roger, V., Sorlie, P., Steinberger, J., Thom, T., Wilson, M., Hong, Y., for the American Heart Association Statistics Comm, (2008). Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117: e25-e146 [Full Text]  
• Padera, R. F. Jr., Schoen, F. J. (2008). Pathology of Cardiac Surgery. Card Surg Adult 3: 111-178 [Full Text]  
• Chen, F. Y., Cohn, L. H. (2008). Mitral Valve Repair. Card Surg Adult 3: 1013-1030 [Full Text]  
• Oceandy, D., Yusoff, R., Baudoin, F. M., Neyses, L., Ray, S. G. (2007). Promoter polymorphism of the matrix metalloproteinase 3 gene is associated with regurgitation and left ventricular remodelling in mitral valve prolapse patients. Eur J Heart Fail 9: 1010-1017 [Abstract] [Full Text]  
• Scordo, K. A. (2007). Medication Use and Symptoms in Individuals With Mitral Valve Prolapse Syndrome. Clin Nurs Res 16: 58-71 [Abstract]  
• Charitakis, K., Basson, C. T. (2007). Degenerating Heart Valves: Fill Them up With Filamin?. Circulation 115: 2-4 [Full Text]  
• Fleisher, L. A., Beckman, J. A., Brown, K. A., Calkins, H., Chaikof, E. L., Fleischmann, K. E., Freeman, W. K., Froehlich, J. B., Kasper, E. K., Kersten, J. R., Riegel, B., Robb, J. F. (2007). ACC/AHA 2006 Guideline Update on Perioperative Cardiovascular Evaluation for Noncardiac Surgery: Focused Update on Perioperative Beta-Blocker Therapy -- A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Anesth. Analg. 104: 15-26 [Abstract] [Full Text]  
• Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C. Jr, Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O'Gara, P. T., O'Rourke, R. A., Otto, C. M., Shah, P. M., Shanewise, J. S., Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Anderson, J. L., Antman, E. M., Faxon, D. P., Fuster, V., Halperin, J. L., Hiratzka, L. F., Hunt, S. A., Lytle, B. W., Nishimura, R., Page, R. L., Riegel, B. (2006). ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 48: e1-e148 [Full Text]  
• Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C. Jr, Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O'Gara, P. T., O'Rourke, R. A., Otto, C. M., Shah, P. M., Shanewise, J. S., Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Anderson, J. L., Antman, E. M., Faxon, D. P., Fuster, V., Halperin, J. L., Hiratzka, L. F., Hunt, S. A., Lytle, B. W., Nishimura, R., Page, R. L., Riegel, B. (2006). ACC/AHA 2006 Practice Guidelines for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 48: 598-675 [Full Text]  
• Gunduz, H., Arinc, H., Kayardi, M., Akdemir, R., Ozyildirim, S., Uyan, C. (2006). Heart rate turbulence and heart rate variability in patients with mitral valve prolapse. Europace 8: 515-520 [Abstract] [Full Text]  
• Kizer, J. R., Devereux, R. B. (2005). Clinical practice. Patent foramen ovale in young adults with unexplained stroke.. NEJM 353: 2361-2372 [Full Text]  
• Rubenfeld, G. D., Caldwell, E., Peabody, E., Weaver, J., Martin, D. P., Neff, M., Stern, E. J., Hudson, L. D. (2005). Incidence and outcomes of acute lung injury.. NEJM 353: 1685-1693 [Abstract] [Full Text]  
• Araujo, C G S, Chaves, C P G (2005). Adult women with mitral valve prolapse are more flexible. Br. J. Sports. Med. 39: 720-724 [Abstract] [Full Text]  
• Roberts, R. (2005). Another Chromosomal Locus for Mitral Valve Prolapse: Close but No Cigar. Circulation 112: 1924-1926 [Full Text]  
• Nesta, F., Leyne, M., Yosefy, C., Simpson, C., Dai, D., Marshall, J. E., Hung, J., Slaugenhaupt, S. A., Levine, R. A. (2005). New Locus for Autosomal Dominant Mitral Valve Prolapse on Chromosome 13: Clinical Insights From Genetic Studies. Circulation 112: 2022-2030 [Abstract] [Full Text]  
• Scordo, K. A. (2005). Mitral Valve Prolapse Syndrome Health Concerns, Symptoms, and Treatments. West J Nurs Res 27: 390-405 [Abstract]  
• Maron, B. J., Ackerman, M. J., Nishimura, R. A., Pyeritz, R. E., Towbin, J. A., Udelson, J. E. (2005). Task Force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and Marfan syndrome. J Am Coll Cardiol 45: 1340-1345 [Full Text]  
• Bursi, F., Enriquez-Sarano, M., Nkomo, V. T., Jacobsen, S. J., Weston, S. A., Meverden, R. A., Roger, V. L. (2005). Heart Failure and Death After Myocardial Infarction in the Community: The Emerging Role of Mitral Regurgitation. Circulation 111: 295-301 [Abstract] [Full Text]  
• Salem, D. N., Stein, P. D., Al-Ahmad, A., Bussey, H. I., Horstkotte, D., Miller, N., Pauker, S. G. (2004). Antithrombotic Therapy in Valvular Heart Disease--Native and Prosthetic: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126: 457S-482S [Abstract] [Full Text]  
• Albers, G. W., Amarenco, P., Easton, J. D., Sacco, R. L., Teal, P. (2004). Antithrombotic and Thrombolytic Therapy for Ischemic Stroke: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126: 483S-512S [Abstract] [Full Text]  
• FRIEDLANDER, A. H., MARDER, S. R., SUNG, E. C., CHILD, J. S. (2004). Panic disorder: Psychopathology, medical management and dental implications. Journal of the American Dental Association 135: 771-778 [Abstract] [Full Text]  
• Lau, E.W, Prasad, N (2004). Functional ventricularisation of the left atrium--severe mitral valve prolapse paradoxically resulting in minimal regurgitation. Eur J Echocardiogr 5: 82-85 [Abstract] [Full Text]  
• Grande-Allen, K. J., Griffin, B. P., Ratliff, N. B., Cosgrove, D. M. III, Vesely, I. (2003). Glycosaminoglycan profiles of myxomatous mitral leaflets and chordae parallel the severity of mechanical alterations. J Am Coll Cardiol 42: 271-277 [Abstract] [Full Text]  
• Avierinos, J.-F., Brown, R. D., Foley, D. A., Nkomo, V., Petty, G. W., Scott, C., Enriquez-Sarano, M. (2003). Cerebral Ischemic Events After Diagnosis of Mitral Valve Prolapse: A Community-Based Study of Incidence and Predictive Factors. Stroke 34: 1339-1344 [Abstract] [Full Text]  
• Oppenheimer, S. (2003). Editorial Comment: Is MVP an MVP in Ischemic Cerebral Events?. Stroke 34: 1345-1345 [Full Text]  
• Evangelopoulos, M E, Alevizaki, M, Toumanidis, S, Sotou, D, Evangelopoulos, C D, Koutras, D A, Stamatelopoulos, S F, Mavrikakis, M (2003). Mitral valve prolapse in systemic lupus erythematosus patients: clinical and immunological aspects. Lupus 12: 308-311 [Abstract]  
• Kumanohoso, T., Otsuji, Y., Yoshifuku, S., Matsukida, K., Koriyama, C., Kisanuki, A., Minagoe, S., Levine, R. A., Tei, C. (2003). Mechanism of higher incidence of ischemic mitral regurgitation in patients with inferior myocardial infarction: Quantitative analysis of left ventricular and mitral valve geometry in 103 patients with prior myocardial infarction. J. Thorac. Cardiovasc. Surg. 125: 135-143 [Abstract] [Full Text]  
• Zhang, Y., Niu, J., Kelly-Hayes, M., Chaisson, C. E., Aliabadi, P., Felson, D. T. (2002). Prevalence of Symptomatic Hand Osteoarthritis and Its Impact on Functional Status among the Elderly: The Framingham Study. Am J Epidemiol 156: 1021-1027 [Abstract] [Full Text]  
• Irvine, T, Li, X K, Sahn, D J, Kenny, A (2002). Assessment of mitral regurgitation. Heart 88: iv11-19 [Full Text]  
• Pellerin, D, Brecker, S, Veyrat, C (2002). Degenerative mitral valve disease with emphasis on mitral valve prolapse. Heart 88: iv20-28 [Full Text]  
• Gaba, R. C., Carlos, R. C., Weadock, W. J., Reddy, G. P., Sneider, M. B., Cascade, P. N. (2002). Cardiovascular MR Imaging: Technique Optimization and Detection of Disease in Clinical Practice. RadioGraphics 22: e6-e6 [Abstract] [Full Text]  
• Freed, L. A., Benjamin, E. J., Levy, D., Larson, M. G., Evans, J. C., Fuller, D. L., Lehman, B., Levine, R. A. (2002). Mitral valve prolapse in the general population: the benign nature of echocardiographic features in the Framingham Heart Study. J Am Coll Cardiol 40: 1298-1304 [Abstract] [Full Text]  
• Sutton, M. S. J., Weyman, A. E. (2002). Mitral Valve Prolapse Prevalence and Complications: An Ongoing Dialogue. Circulation 106: 1305-1307 [Full Text]  
• Avierinos, J.-F., Gersh, B. J., Melton, L. J. III, Bailey, K. R., Shub, C., Nishimura, R. A., Tajik, A. J., Enriquez-Sarano, M. (2002). Natural History of Asymptomatic Mitral Valve Prolapse in the Community. Circulation 106: 1355-1361 [Abstract] [Full Text]  
• Lee, T.-H., Hsu, W.-C., Chen, C.-J., Chen, S.-T. (2002). Etiologic Study of Young Ischemic Stroke in Taiwan. Stroke 33: 1950-1955 [Abstract] [Full Text]  
• Hoffman, J. I. E., Kaplan, S. (2002). The incidence of congenital heart disease. J Am Coll Cardiol 39: 1890-1900 [Abstract] [Full Text]  
• Atalar, E., Aqil, T., Aytemir, K., Haznedarolu, I., Ozer, N., Kiliq, H., Kuru, G., Aksdyek, S., Ovtinq, K., Kes, S., Kirazli, e., Ozmen, F. (2002). Diminished Global Fibrinolytic Capacity in Patients With Mitral Valve Prolapse Is Associated With Transient Ischemic Attacks. CLIN APPL THROMB HEMOST 8: 41-44 [Abstract]  
• Jouven, X., Ducimetiere, P. (2001). Exercise testing: do frequent premature ventricular depolarizations represent a new criterion of positivity?. Eur Heart J 22: 1759-1761  
• Smolens, I. A., Pagani, F. D., Deeb, G. M., Prager, R. L., Sonnad, S. S., Bolling, S. F. (2001). Prophylactic mitral reconstruction for mitral regurgitation. Ann. Thorac. Surg. 72: 1210-1216 [Abstract] [Full Text]  
• Mohty, D., Orszulak, T. A., Schaff, H. V., Avierinos, J.-F., Tajik, J. A., Enriquez-Sarano, M. (2001). Very Long-Term Survival and Durability of Mitral Valve Repair for Mitral Valve Prolapse. Circulation 104 : I-1-I-7 [Abstract] [Full Text]  
• Priori, S.G., Aliot, E., Blomstrom-Lundqvist, C., Bossaert, L., Breithardt, G., Brugada, P., Camm, A.J., Cappato, R., Cobbe, S.M., Di Mario, C., Maron, B.J., McKenna, W.J., Pedersen, A.K., Ravens, U., Schwartz, P.J., Trusz-Gluza, M., Vardas, P., Wellens, H.J.J., Zipes, D.P. (2001). Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J 22: 1374-1450  
• Aessopos, A., Farmakis, D., Karagiorga, M., Voskaridou, E., Loutradi, A., Hatziliami, A., Joussef, J., Rombos, J., Loukopoulos, D. (2001). Cardiac involvement in thalassemia intermedia: a multicenter study. Blood 97: 3411-3416 [Abstract] [Full Text]  
• Brookfield;, E. G., Steinberger, J., Moller, J. H., Berry, J. M., Sinaiko, A. R. (2001). Echocardiography in Healthy Children. Pediatrics 107: 1237-1237 [Full Text]  
• Zouridakis, E. G., Parthenakis, F. I., Kochiadakis, G. E., Kanoupakis, E. M., Vardas, P. E. (2001). QT dispersion in patients with mitral valve prolapse is related to the echocardiographic degree of the prolapse and mitral leaflet thickness. Europace 3: 292-298 [Abstract]  
• Albers, G. W., Amarenco, P., Easton, J. D., Sacco, R. L., Teal, P. (2001). Antithrombotic and Thrombolytic Therapy for Ischemic Stroke. Chest 119: 300S-320S [Full Text]  
• Enriquez-Sarano, M. (2000). Reply. J Am Coll Cardiol 36: 2014-2015 [Full Text]  
• Jouven, X., Zureik, M., Desnos, M., Courbon, D., Ducimetiere, P. (2000). Long-Term Outcome in Asymptomatic Men with Exercise-Induced Premature Ventricular Depolarizations. NEJM 343: 826-833 [Abstract] [Full Text]  
• Stefanadis, C., Toutouzas, P. (2000). Mitral valve prolapse: The Merchant of Venice or Much Ado About Nothing ?. Eur Heart J 21: 255-258  
• Jeresaty, R. M., Cheng, T. O., Freed, L. A., Levy, D., Levine, R. A., Evans, J. C., Benjamin, E. J. (1999). Mitral-Valve Prolapse. NEJM 341: 1471-1472 [Full Text]  
• (1999). Has the Importance of Mitral Valve Prolapse Been Overestimated?. Journal Watch Dermatology 1999: 14-14 [Full Text]  
• (1999). Has the Importance of Mitral Valve Prolapse Been Overestimated?. JWatch Psychiatry 1999: 16-16 [Full Text]  
• (1999). How Prevalent Is Mitral-Valve Prolapse?. Journal Watch Cardiology 1999: 1-1 [Full Text]  
• (1999). Has the Importance of Mitral Valve Prolapse Been Overestimated?. JWatch General 1999: 1-1 [Full Text]  
• Gilon, D., Buonanno, F. S., Joffe, M. M., Leavitt, M., Marshall, J. E., Kistler, J. P., Levine, R. A. (1999). Lack of Evidence of an Association between Mitral-Valve Prolapse and Stroke in Young Patients. NEJM 341: 8-13 [Abstract] [Full Text]  
• Nishimura, R. A., McGoon, M. D. (1999). Perspectives on Mitral-Valve Prolapse. NEJM 341: 48-50 [Full Text]